Skip to main content

Table 1 Basic features of patients among the three groups

From: The effects of neostigmine on postoperative cognitive function and inflammatory factors in elderly patients – a randomized trial

 

Control group

(n = 42)

0.04 mg/kg group

(n = 40)

0.02 mg/kg group

(n = 38)

P-value

Age (year, \( \overline{\mathrm{x}} \)±s)

72.9 ± 4.9

73.3 ± 6.2

72.5 ± 6.1

0.825

Sex (n,%)

 Male

22 (52)

21 (53)

20 (53)

0.751

 Female

20 (48)

19 (47)

18 (47)

0.648

BMI (kg/m2, \( \overline{\mathrm{x}} \)±s)

23.5 ± 2.9

22.9 ± 2.7

22.7 ± 2.9

0.233

Preoperative MMSE score [M (IQR)]

25 (23, 26)

25 (23, 27

25 (24, 27)

0.546

ASA grade (n,%)

   

0.643

 I–II

21 (50)

24 (60)

21 (55.3)

 

 III

21 (50)

16 (40)

17 (44.7)

 

Type of surgery (n,%)

   

0.735

 Gastric cancer

23 (54.7)

19 (47.5)

15 (39.5)

 

 Colon cancer

19 (45.3)

21 (52.5)

23 (60.5)

 

Diabetes (n,%)

6 (14)

8 (20)

5 (13)

0.136

Arrhythmia (n,%)

3 (7)

6 (15)

4 (10)

0.223

Stroke (n,%)

2 (5)

1 (2.5)

3 (7.9)

0.375

Anemia (n,%)

2 (5)

2 (5)

1 (2.6)

0.218

Hypertension (n,%)

15 (35.7)

14 (35)

13 (34)

0.093

Coronary heart disease (n,%)

3 (7)

4 (10)

5 (13)

0.835

Hypoproteinemia (n,%)

2 (5)

1 (2.5)

2 (5)

0.415